Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep;9(9):1205-1218.
doi: 10.2217/epi-2016-0165. Epub 2017 Aug 15.

Effect of methotrexate/vitamin B12 on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity

Victoria J Forster  1 , Alex McDonnell  2 , Rachel Theobald  2 , Jill A McKay  2
Affiliations

Effect of methotrexate/vitamin B12 on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity

Victoria J Forster et al. Epigenomics. 2017 Sep.

Abstract

Methotrexate (MTX) is administered to treat childhood acute lymphoblastic leukemia (ALL). It acts by inhibiting dihydrofolate reductase which reduces methyltetrahydrofolate, a key component in one carbon metabolism, thus reducing cell proliferation. Further perturbations to one carbon metabolism, such as reduced vitamin B12 levels via the use of nitrous oxide for sedation during childhood ALL treatment, may increase neurotoxicity risk. With B12 as an enzymatic cofactor, methyltetrahydrofolate is essential to produce methionine, which is critical for DNA methylation. We investigated global and gene specific DNA methylation in neuronal cell lines in response to MTX treatment and vitamin B12 concentration individually, and in combination.

Results: MTX treatment alone significantly increased LINE-1 methylation in SH-SY5Y (p = 0.040) and DAOY (p < 0.001), and increased FKBP5 methylation in MO3.13 cells (p = 0.009).

Conclusion: We conclude that altered DNA methylation of brain/central nervous system cells could be one mechanism involved in MTX treatment-related neurotoxicities and neurocognitive late effects in ALL survivors.

Keywords: childhood acute lymphoblastic leukemia; epigenetic; late effects; methotrexate; neurocognition; neurotoxicity; one carbon metabolism; vitamin B12.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

This project was funded through the North of England Children's Cancer Research Fund (NECCR), the Wellcome Trust & Wellcome Trust Institutional Strategic Support Fund, the Rank Prize Fund and the JGW Patterson Foundation, grant number BH152502. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Figures

<b>Figure 1.</b>
Figure 1.. Summary diagram of the main pathways involved in cellular one-carbon metabolism including the production of S-adenosylmethionine for methylation of DNA.
Dietary factors able to influence this pathway are highlighted in red, enzymes driving biological reactions are highlighted in blue/bold. The influence of methotrexate on this pathway through the inhibition of dihydrofolate reductase enzyme is highlighted in red/italics. Additional abbreviations: DHF, THF, SHMT, MTRR, MTHFR, BHMT, CBS, COMT, DNMT, SAH. BHMT: Betaine-homocysteine S-methyltransferase; CBS: Cystathione beta synthase; COMT: cystathionine beta synthase; DHF: Dihydrofolate; DHFR: Dihydrofolate reductase; DNMT: DNA methyltransferase; MTHFR: Methylenetetrahydrofolate reductase; MTRR: Methionine synthase reductase; MTX: Methotrexate; SAH: S-adenosylhomocysteine; SAM: S-adenosylmethionine; SHMT: Serine hydroxymethyltransferase; THF: Tetrahydrofolate. Modified with permission from [1] (2011).
<b>Figure 2.</b>
Figure 2.. Schema depicting 3 × 3 factorial study design.
The experiment was carried out in triplicate for each cell line, resulting in an n = 9 per group to investigate the main effects of MTX and vitamin B12 treatments alone, and n = 3 to investigate the interaction between treatments. MTX: Methotrexate.
<b>Figure 3.</b>
Figure 3.. Effect of (A) MTX treatment (B) vitamin B12 concentration and (C) interaction between treatments on proliferation of DAOY, SH-SY5Y and MO3.13 cells 4 days after seeding.
Cells were seeded in T25 cm2 flasks at the following starting densities (total cell number): MO3.13 and DAOY; 1 × 105 - SH-SY5Y - 2 × 105. Data were analyzed using univariate ANOVA, n = 9 per treatment group for main effects (i.e., MTX and vitamin B12 treatments) and n = 3 for interaction, error bars represent 95% CIs. P-values relate to effect of treatment on methylation; where groups do not share the same letter post hoc tests revealed significant differences (p > 0.05). MTX: Methotrexate.
<b>Figure 4.</b>
Figure 4.
Effect of MTX treatment on (A) LINE1 (B) HOXA4 and (C) FKBP5 DNA methylation in DAOY, SH-SY5Y and MO3.13 cells. Data were analyzed using univariate ANOVA, n = 9 per treatment group*, error bars represent 95% CIs. P-values relate to effect of treatment on methylation; where groups do not share the same letter post hoc tests revealed significant differences (p > 0.05). (*with the exception of HOXA4 methylation in MO3.13 cells where n = 7, 9 and 8 respectively for 0, 1 and 5 μM MTX groups). MTX: Methotrexate.
<b>Figure 5.</b>
Figure 5.. Mean LINE1 methylation of DAOY treated with various concentrations of methotrexate and vitamin B12.
n = 3 per treatment group. Data were analyzed using univariate ANOVA, p = 0.038 for interaction between MTX and vitamin B12 treatments. Error bars represent 95% CIs. MTX: Methotrexate.
See this image and copyright information in PMC

References

    1. Mckay JA, Mathers JC. Diet induced epigenetic changes and their implications for health. Acta Physiol. (Oxf.) 2011;202(2):103–118. - PubMed
    1. Dufourg MN, Landman-Parker J, Auclerc MF, et al. Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children. Leukemia. 2007;21(2):238–247. - PubMed
    1. Lobel U, Trah J, Escherich G. Severe neurotoxicity following intrathecal methotrexate with nitrous oxide sedation in a child with acute lymphoblastic leukemia. Pediatr. Blood Cancer. 2015;62(3):539–541. - PubMed

    2. •• Clinical case report implying concomitant use of nitrous oxide and methotrexate in severe neurotoxicity.

    1. Cheung YT, Krull KR. Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review. Neurosci. Biobehav. Rev. 2015;53:108–120. - PMC - PubMed

    2. • Comprehensive review of long-term neurocognitive outcomes of survivors of childhood leukemia.

    1. Van Der Plas E, Nieman BJ, Butcher DT, et al. Neurocognitive late effects of chemotherapy in survivors of acute lymphoblastic leukemia: focus on methotrexate. J. Can. Acad. Child Adolesc. Psychiatry. 2015;24(1):25–32. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources